Impact of CES1 Genotype on Remimazolam — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Impact of CES1 Genotype on Remimazolam — Stella

View on ClinicalTrials.gov

Recruiting

Back to Adult trials

Trial locations(1 site)

South Korea

Korea University Guro Hospital, Seoul

Key details

Sponsor

Korea University Guro Hospital

Enrollment target

~120 participants

Started

September 2023

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

19 Years – 70 Years

Last updated October 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.